More articles from MTA I: Prostate/GU Posters

You have access
The value of anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT in the diagnosis of recurrent prostate carcinoma: a meta-analysis
Jigang yang

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1441;
You have access
Bone scan response to newer therapies in castration resistant prostate cancer.
Ramya S rao, Renee Moadel, kwang chun, Leonard Freeman and Benjamin Gartrell

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1453;
You have access
Renal cell carcinoma: clinical and prognostic value of 18F-FDG-PET/CT after surgery
Pierpaolo Alongi, Marianna Spallino, Luigi Gianolli and Maria Picchio

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1432;
You have access
18F DCFBC compared to 18F NaF in metastatic prostate cancer
Maria Lindenberg, Ismail Turkbey, Stephen Adler, Karen Kurdziel, Fatima Karzai, Anna Couvillon, Ravi Madan, William Dahut, Martin Pomper and Pete Choyke

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1440;
You have access
Dual Time Point PET/CT Acquisition Using Ga-68-PSMA-Radioligand
Kambiz Rahbar, Thomas Vehren, Martin Boegemann, Hans-Joerg Breyholz, Michael Schaefers and Matthias Weckesser

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1437;
You have access
Imaging patients with breast and prostate cancers using combined ¹⁸F NaF/¹⁸F FDG and TOF simultaneous PET/ MRI
Andrei Iagaru, Ryogo Minamimoto, Mehran Jamali, Amir Barkhodari, Piotr Obara, Andreas Loening, Valentina Taviani, Erik Mittra, Sanjiv Gambhir and Shreyas Vasanawala

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1455;
You have access
Preliminary analysis of dynamic [68Ga]PSMA^HBED-CC PET/MRI in primary prostate cancer
Alexander Haug, Thomas Helbich, Wolfgang Wadsak, Sarah Pfaff, Martin Susani, Shahrokh Shariat, Marcus Hacker, Sabrina Hartenbach, Jan-Marc Lieskovsky and Markus Hartenbach

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1436;
You have access
A regression model to predict tumor cellularity in patients with prostate cancer and low FDG uptake
Xiaofei Wang, Peng Huang, Shirley Yang and Richard Wahl

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1450;
You have access
¹⁸F-choline PET/CT in prostate cancer: is a dual-phase study really needed?
Simona Ben-Haim, Tima Davidson, Zvi Symon, Zohar Dotan, Raanan Berger and Elinor Goshen

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1443;
You have access
Evaluation of FDG PET/CT measurement parameters for prediction of the prognosis after Sunitinib Therapy in Renal Cell Carcinoma
Ryogo Minamimoto, Amir Barkhodari, Lauren Harshman, Andrew Quon and Sandy Srinivas

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1429;

Main menu

User menu

Search

More articles from MTA I: Prostate/GU Posters

Pages